As people learn more about the threat from substandard and counterfeit medicines, it is becoming clear that it is a far greater problem than previously thought. It is also a scourge that is most acutely felt in developing countries, where fake and low-quality pharmaceuticals kill more than 500,000 people per year and affect millions more by contributing to the emergence of diseases that are resistant to existing treatments.
Compounding the problem is the approach taken by policymakers in the developing world, who are far more likely to look for solutions abroad than at home. This shortsightedness is a grave mistake that impedes innovation and progress. When it comes to tackling high-impact health challenges like the proliferation of fake or inferior drugs, local solutions and local innovations are not only likely to be central to any successful effort, they have the potential to provide benefits that go far beyond the scope of the original problem.
Throughout the developing world, but most evidently in Africa, two groups are interested in finding tools to combat the menace of bad drugs. One group, composed of students, entrepreneurs and researchers, seeks solutions that are local, original and tailored to the needs of their societies. Its members are quick to share ideas and eager to collaborate.
While this group has produced some innovative solutions — for example, Ghanaian entrepreneur Bright Simmons is using mobile technology to address the counterfeit-drug problem — many more passionate local inventors and entrepreneurs must get involved.
The other group is made up of government officials, including regulators. They too are deeply concerned about the scourge of low-quality and fake drugs, but they are reluctant to rely on local innovation. In their minds, the solutions already exist, in the form of high-end technology designed and developed in the world’s richest countries. The challenge, for this group, lies in finding the financial resources to import these technologies.
For the leaders of developing countries, the effort needed to create an ecosystem that supports innovation simply appears too great and the return on investment too little. At countless conferences and symposia, ministry officials and government personnel insist that funds must be found to import solutions a la carte.
Research and innovation, or engagement with local entrepreneurs and inventors, is, unfortunately, never on the agenda. There is simply little interest in tapping into the enormous pool of intellect, passion and energy at home.
Officials would be wise to reconsider. There is mounting evidence that sustainable solutions must have local support and local partners; raising funds to import solutions from abroad addresses just one part of the challenge.
Many countries lack the resources to install, operate and maintain equipment that has not been designed locally. As misuse and neglect causes equipment to malfunction, more funds become required or the program simply dies. Not only does this approach fail to nurture local ecosystems of innovation, which is deeply frustrating, it also repeatedly fails to solve the problem at hand.
While some solutions in the area of drug-quality testing have come from African entrepreneurs like Simmons, such examples are extremely rare, and many are developed in the diaspora with the support of organizations from outside the region. For the most part, such initiatives never engage local students. Local curricula do not focus on local challenges or promote local innovation.
And yet, local talent is critical for solutions that are both original and sustainable. Indeed, by nurturing an inclusive culture of research, local innovation has the potential to provide benefits that extend far beyond the specific problem that is being addressed.
Nurturing the participation of underrepresented groups and creating opportunities for education and learning create goodwill and promote transparency and accountability. Building a stable foundation for future research also enables more productive public-private partnerships and stronger links between academia and domestic industry, thereby promoting economic growth.
Foreign organizations, such as aid agencies or pharmaceutical companies, do have a role to play in boosting local innovation. They can support it financially, create new partnerships, and encourage policymakers to give it more credence.
The international community has a role to play as well. This year, the UN is set to adopt the Sustainable Development Goals, marking the start of the next phase of global efforts to eradicate poverty and improve health.
As the example of developing countries’ ongoing fight against counterfeit and low-quality medicines shows, success will depend — far more often than not — on local innovation.
Muhammad Hamid Zaman is a professor of biomedical engineering at Boston University.
Copyright: Project Syndicate
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
Former president Ma Ying-jeou’s (馬英九) trip to China provides a pertinent reminder of why Taiwanese protested so vociferously against attempts to force through the cross-strait service trade agreement in 2014 and why, since Ma’s presidential election win in 2012, they have not voted in another Chinese Nationalist Party (KMT) candidate. While the nation narrowly avoided tragedy — the treaty would have put Taiwan on the path toward the demobilization of its democracy, which Courtney Donovan Smith wrote about in the Taipei Times in “With the Sunflower movement Taiwan dodged a bullet” — Ma’s political swansong in China, which included fawning dithyrambs